|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02196 FOSUN PHARMA
Nominal 
14.240 -0.180 (-1.248%) Ranking Overview
Ranking based on 5 research report(s)
Average Ranking 2.20
|
Strong Buy (1)
0
|
Buy (2)
4
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | 90.00 RMB (cts) | |
| Net Profit | 2,398.61 RMB (MIL) | DPS | 27.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | 2,979.00 | 111.00 | 31.00 | -- | 3,190.00 | 2,506.00 |
| 2025 | 3,570.00 | 134.00 | 39.00 | -- | 4,074.00 | 3,253.00 |
| 2026 | 4,273.00 | 160.00 | 48.15 | -- | 4,986.00 | 3,906.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | 2,506.00 | 93.90 | 28.20 | CITIGROUP | Buy | 20.00 | 28/08/2024 | |
| 2024 | 3,190.00 | 119.00 | -- | CITIC SEC | Buy | 19.00 | 10/09/2024 | |
| 2024 | 2,995.00 | 117.00 | 37.57 | MORGAN STANLEY | Overweight | 16.00 | 27/06/2024 | |
| 2024 | 2,979.00 | 111.00 | 30.00 | CLSA | OutPerform | 14.60 | 29/08/2024 | |
| 2024 | 2,832.00 | 110.00 | 32.00 | HSBC | Hold | 13.00 | 19/09/2024 | |
| 2025 | 3,253.00 | 121.80 | 36.60 | CITIGROUP | -- | -- | 28/08/2024 | |
| 2025 | 4,074.00 | 152.00 | -- | CITIC SEC | -- | -- | 10/09/2024 | |
| 2025 | 3,767.00 | 147.00 | 47.58 | MORGAN STANLEY | -- | -- | 27/06/2024 | |
| 2025 | 3,570.00 | 134.00 | 40.00 | CLSA | -- | -- | 29/08/2024 | |
| 2025 | 3,419.00 | 133.00 | 38.00 | HSBC | -- | -- | 19/09/2024 | |
| 2026 | 4,122.00 | 154.40 | 46.30 | CITIGROUP | -- | -- | 28/08/2024 | |
| 2026 | 4,986.00 | 187.00 | -- | CITIC SEC | -- | -- | 10/09/2024 | |
| 2026 | 4,665.00 | 182.00 | 58.85 | MORGAN STANLEY | -- | -- | 27/06/2024 | |
| 2026 | 4,273.00 | 160.00 | 50.00 | CLSA | -- | -- | 29/08/2024 | |
| 2026 | 3,906.00 | 152.00 | 44.00 | HSBC | -- | -- | 19/09/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 28/11/2024 11:18 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,224,799 |
| %Change | -31.332% |
| EPS / (LPS) | RMB 0.460 |
| NBV Per Share (¥) | RMB 17.561 |